Rodent study indicates that the motor cortex becomes disconnected during episodes of involuntary and uncontrollable movements ...
F-DOPA PET−guided, dose-escalated, hypofractionated proton beam therapy led to improved OS in older patients with newly ...
There were no differences between the groups in the use of other PD drugs, including dopamine agonists, COMT inhibitors, anticholinergic agents, and amantadine. Cumulative L-dopa exposure was ...
Discover how dopamine’s unexpected role in breaking down harmful plaques could revolutionize Alzheimer's treatment and ...
Alternatives to L-dopa for initial treatment of Parkinson's disease (PD) should be considered for patients younger than 65-70 years. Nonmotor symptoms are very common in PD and include ...
NLX-101 (F15599) is under development for the treatment of Rett syndrome and depression. The drug candidate is administered by oral route. The drug candidate is a new chemical entity (NCE). The drug ...
Mavoglurant is under development for the treatment of cocaine use disorder, alcohol use disorder and for language learning in young children with fragile X syndrome (FXS). The drug candidate is ...
Anticonvulsants used to treat epilepsy work on GABA. And drugs used to treat Parkinson’s disease, such as L-DOPA, promote dopamine function. Other Brain Cells (Glia) Although neurons are ...
NeuroQuiet is an advanced auditory support supplement that takes hearing experience to the next level. It strategically ...
A registered dietitian shares 13 of the healthiest energy drinks available on the market, based on nutritional value and ingredients.